Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Zentera Therapeutics is a biopharmaceutical company.
Beijing Yuanxin is a technology company that offers an integrated healthcare platform for pharmaceutical distribution and health insurance.
Yuanxin Huibao is a health insurance technology service provider.
Zion Pharma is a drug discovery platform.
Turnstone Biologics is a privately-held clinical stage biotech company.
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.
Dingdang Kuaiyao is an online-to-offline drug purchasing and delivery platform.
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations.
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.
Theseus Pharmaceuticals is a technology-based company.
Medical device supplier based in Shanghai.
Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases.
Emendo is a biotechnology company
SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.
Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.
BioNova Pharma biopharmaceutical company that develops treatments for cancer.
Zhaoke Ophthalmology Pharmaceutical is a Pharmaceutical platform.
BioShin is a clinical stage biopharmaceutical company.
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.
ReViral is a biotechnology company that develops and offers antiviral therapies for patients.
MobileODT is an AI-based health-tech company that develops medical device technologies for cervical cancer screening.
OrbiMed has invested in 288 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OrbiMed's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Therapeutics, Medical. The firm invests across 24 different industry categories.
Among tracked funding rounds, SAGE Therapeutics received $650.0M in a Post Ipo Equity round. OrbiMed's total known invested capital is $31.2B.
OrbiMed's average investment size is $108.2M across its portfolio of 288 companies.
Recent OrbiMed portfolio additions include Zentera Therapeutics, Beijing Yuan Xin, Yuanxin Huibao, Zion Pharma, Turnstone Biologics. These companies were founded in 2020 or later.